KIR/HLA pleiotropism: protection against both HIV and opportunistic infections - Test2 - elhamkhani - TriplyDB

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

http://www.wikidata.org/entity/Q28469038

about

Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression Significant increase in cytotoxic T lymphocytes and natural killer cells by triphala: a clinical phase I study Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience Suppression of a Natural Killer Cell Response by Simian Immunodeficiency Virus Peptides Impaired antibody response causes persistence of prototypic T cell-contained virus Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication.Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.Host genetics influences on HIV type-1 disease.A whole genome association study of mother-to-child transmission of HIV in Malawi.HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.Copy number variation of KIR genes influences HIV-1 control.Association of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys.Innate immunity against HIV: a priority target for HIV prevention research Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.The immune response during acute HIV-1 infection: clues for vaccine development.Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.KIR/HLA interactions and pathogen immunity Immunodeficiency lentiviral infections in natural and non-natural hosts.Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1 Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.Innate immunity in acute HIV-1 infection Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.KIR-HLA intercourse in HIV disease Structural insights into activation of antiviral NK cell responses Host genetic determinants of HIV pathogenesis: an immunologic perspective HIV-1 dynamics: a reappraisal of host and viral factors, as well as methodological issues.The Yin and Yang of HLA and KIR in human disease Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques.KIR2DL4 copy number variation is associated with CD4+ T-cell depletion and function of cytokine-producing NK cell subsets in SIV-infected Mamu-A*01-negative rhesus macaques Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature.

P2860

Q21091106-075E9451-C57C-4841-87CF-F13D2C311650 Q21296692-F6AB8E5A-0D05-4356-AA02-D66804BE289E Q26776114-E22E3057-49A1-47A6-B718-0EAA325F775C Q26850968-2FC0B9E5-1242-42B6-A73C-3CC8E5B3A3BE Q27317377-738035B2-F731-4386-9EDB-A494CB8D2907 Q27331309-F19F17A6-8C72-4C85-BA87-C3D83ED06F94 Q28610728-5F9D01B2-294A-4E7F-8465-C13ECA2B6134 Q28751706-087BAF2B-D6E4-4614-8288-569CAB812849 Q33621321-3DE6D2AF-B359-4396-8FC0-B030CA724196 Q33657935-04D6AEEA-1942-45E9-9A42-0DE40B3CDED2 Q33772422-873D7CEC-57DF-40CA-B388-5461B2AB27D1 Q33775595-AF6BC2E8-5014-46CF-8914-136B49F1D7B7 Q33865715-071F0EA6-DB04-4785-87DA-CE691887292B Q33918894-98F10F4A-E745-440E-9A26-2C77324D781E Q34047774-F8E97A60-B52E-45FB-886C-4D0B90324074 Q34056087-1F7B59BA-0038-4C14-BCB0-8F2CDD0FF425 Q34090869-80E12402-7869-4F5D-B335-6B290D3BC3A5 Q34109760-11C364F1-EC09-487A-9A52-12B993620B21 Q34243462-31CE601B-9D62-4C63-A97C-5C317638E704 Q34493947-6F186967-FF82-4DDE-B419-A77F8DED1B6D Q34614862-AC4E584C-BE47-49B4-B749-103B9EF17D9A Q34741864-8521BDD4-8CB8-4C3B-AB1D-1C56A0AD90A3 Q34995326-511536B3-38FC-4887-8136-1939141BB609 Q35001169-3FDB64B2-3AEE-41C0-9ECD-A9B601FCF499 Q35140973-191FB23D-CFEE-4528-9893-EAAD20B659FB Q35175810-946E8AD6-4458-4DB7-B0DA-0BA438E2B69A Q35641485-E04EAD8B-298A-4921-A30F-C9F7FC98DD11 Q35696991-4641FEB1-1FC9-4874-A5BF-B3A1F486B2CA Q35753686-668E08B3-D1F3-4E2F-920C-9C4C7D459173 Q36009232-23B54A83-99B5-4243-964E-96199417421D Q36296307-66F8998F-5A8D-45FF-8247-F5E406ECFD59 Q36317668-8EA87A08-132E-45D6-8979-6D3E531CD3CC Q36329596-3108CE05-3D52-46D1-83B6-276FC6A3441E Q36395847-06867F78-74DC-433C-8331-125651C920E4 Q36410540-E69E5A52-B3E6-40FC-A5F8-385E1A53B4A3 Q36594176-0AA8DAC5-735B-43E1-8BF5-DD8407668A6D Q36673356-C4208C3E-C35F-48D3-A6B7-9451DD69F61C Q36759934-F232BEE7-A0F1-404E-90FC-B09183C4C740 Q36830203-AB15D92F-F4D8-4278-97C0-53F2D56BDF12 Q36833017-E917D7E3-E091-462E-9E4C-368FA21AA261

P2860

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

http://www.wikidata.org/entity/Q28469038

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@ast

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@en

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@nl

type

label

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@ast

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@en

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@nl

prefLabel

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@ast

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@en

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@nl

P1433

Q28469038-C362F39C-EC7F-49A5-873E-C30ACD33786E

P1476

Q28469038-A67B86F6-900F-4D47-8510-82AF0B2106D1

P2093

Q28469038-2AD22646-5DCE-433B-8409-2BC45FB9755F

Q28469038-3B5B7027-5CB5-4D4A-B63D-57C42459C9A6

Q28469038-6B3504E4-C8C2-4C67-B07D-C12FAC8925D2

Q28469038-902886B3-3792-4D0B-A331-BED122398D15

Q28469038-9AFD0EF1-D9B7-49BB-8CEC-C020EF9042C1

Q28469038-D5DD0B96-EA9F-4B35-B80D-0C175F01C66A

Q28469038-E127508D-D014-45A3-A6E3-56C5DA1F810C

Q28469038-EC2B8955-B63D-4322-9E9E-91C4DD12E9F3

P2860

Q28469038-2D94EF98-E68D-482F-A9A5-8BEA868AB5D2

Q28469038-3A850079-37D9-4C5E-88C5-0BC2D1E296F7

Q28469038-4114C720-4750-465A-8092-9ED3625FF415

Q28469038-45B373A8-5EF8-48E6-974E-136BF0A33F73

Q28469038-4ADB6B21-4F70-47E2-93EF-5A55ED83C1A2

Q28469038-631DF226-A560-4D39-8B5D-8362E513AFA8

Q28469038-71A95107-AD75-4228-9ECC-534CEED13DAB

Q28469038-781A5034-D6C7-4086-BB44-7B3B6E5990E6

Q28469038-80B6573E-98F3-4AF6-A156-723AD77E707C

Q28469038-89AEA98D-F630-4110-9362-30AB029428B0

P304

Q28469038-BAF14CAB-4BBB-4714-A1A5-E584F73A75B9

P31

Q28469038-CBAA6A3D-B335-4417-ABEA-C8C1238A6EEE

P3181

Q28469038-D03138AC-9B05-49AE-9AF2-CD6F054D0A96

P356

Q28469038-416B5161-1E9E-4240-84E5-D3B7A5C9A8BC

P407

Q28469038-8A3AA11C-9D36-4903-A269-0AD8A1832B42

P433

Q28469038-88A0AD81-40A2-492D-8759-E92A4712E25A

P478

Q28469038-1B43CF13-5E86-4A8C-AB39-8F0ECCA85F31

P50

Q28469038-373323EE-3CA2-487A-A28C-F6547990F126

Q28469038-D4DE31C6-2FBF-4BE1-B9E2-BF0326DB05CF

P577

Q28469038-4AFB87DA-8F2F-4364-ACF4-9C9BD29ED08B

P5875

Q28469038-7993E0CC-B791-4DF6-8D5B-C10330790ABC

P698

Q28469038-4E951150-CBB2-410F-A5BD-1E4044E7D67F

P932

Q28469038-3BCF0A1C-8AB6-4226-BF92-C1BF76BA4806

P3181

P356

JOURNAL.PPAT.0020079

P1433

P1476

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

@en

P2093

Gregory D Kirk

http://www.w3.org/2001/XMLSchema#string

James J Goedert

http://www.w3.org/2001/XMLSchema#string

John Trowsdale

http://www.w3.org/2001/XMLSchema#string

Lisa Jacobson

http://www.w3.org/2001/XMLSchema#string

Maureen P Martin

http://www.w3.org/2001/XMLSchema#string

Stephen J O'Brien

http://www.w3.org/2001/XMLSchema#string

Xiaojiang Gao

http://www.w3.org/2001/XMLSchema#string

Ying Qi

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

The influence of HLA genotype on AIDS

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

Long-term HIV-1 infection without immunologic progression

Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues

NK cell recognition

Biology of natural killer cells

Roles of the NKG2D immunoreceptor and its ligands.

NK cells and NKT cells in innate defense against viral infections.

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.

P304

e79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4106632

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.0020079

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Mary Carrington

Susan Buchbinder

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6854485

http://www.w3.org/2001/XMLSchema#string

P698

16933987

http://www.w3.org/2001/XMLSchema#string

P932

1550271

http://www.w3.org/2001/XMLSchema#string